Respiratory diseases of the upper airways can be effectively managed with nebulizer inhalation therapy, as nebulizers allow controlled delivery of medication directly to the upper respiratory tract.

However, many parents and adult patients are convinced that they already know how to perform inhalation correctly. It may seem like a simple procedure, comparable to inhaling steam over a bowl of hot water. This is the main misconception. Most often, inhalations are performed without a nebulizer or incorrectly, which may even be dangerous. Instead of relieving breathing and reducing inflammation, patients risk mucosal burns, worsening edema, or exacerbation of chronic disease. Parents wonder: “We are doing everything right—why is my child getting worse?” Adults assume that any type of inhalation is equally beneficial, failing to distinguish between steam inhalation and modern nebulizer technology.

Nebulizer Therapy: Indications and Rationale

The European Respiratory Society (ERS) notes the global rise in both upper and lower airway diseases among children and adults. Nebulized therapy is recommended in selected clinical settings to deliver drugs in the form of a fine aerosol mist directly to the upper airways and lungs. The core principles are efficacy, patient safety, and adherence to unified standards for devices, procedures, and tailoring therapy to the drug and the patient.

Device ≠ Medication: Why It Matters

Unlike handheld inhalers, nebulizers are sold separately from medications. The actual drug dose delivered to the respiratory tract may vary tenfold or more when switching from an inefficient to a high-efficiency nebulizer system. Deposition of aerosol in the airways is determined by three factors: droplet size, breathing pattern, and airway condition. The most controllable factor is the mass median aerodynamic diameter (MMAD):

• ~5–10 µm — upper airways;
• 2–5 µm — trachea/bronchi;
• <2 µm — peripheral airways/alveoli.

The ERS recommends following the European Standard CEN/EN 13544-1, which standardizes measurement of droplet size, aerosol output, and flow rates. This ensures clinically meaningful comparison of different systems.

Jet vs. Ultrasonic Nebulizers: Which to Choose?

• Jet nebulizers — the most common in Europe; compatible with a broad range of solutions, affordable, do not heat medications.
• Ultrasonic nebulizers — quieter and faster, but may be incompatible with suspensions (e.g., budesonide) and may degrade drugs when heated.

Choice depends on the formulation (solution vs. suspension), required MMAD, clinical indication, and patient convenience.

Clinical ENT Indications: When Nebulizers Are Essential

1. Acute obstructive laryngitis (croup in children)
   • Nebulized budesonide or epinephrine = gold standard.
   • Provides rapid relief, reduces need for intubation.
2. Severe allergic rhinitis or rhinosinusitis with bronchospasm
   • Combination of nebulized antihistamines/steroids with nasal irrigation.
3. Laryngotracheitis, acute subglottic edema
   • Nebulization ensures targeted delivery to larynx and trachea.
4. Mucolytic therapy in viscous secretions
   • Ambroxol, acetylcysteine help liquefy mucus.
5. Chronic inflammatory processes (laryngitis, tracheitis, chronic rhinosinusitis)
   • Prolonged courses: saline or mucolytics improve mucociliary clearance.
6. Postoperative ENT care
   • After septoplasty, sinus or laryngeal surgery — hydration and targeted delivery of antiseptics or steroids.

When Nebulizers Are Not Mandatory

1. Simple viral rhinitis / common cold — nasal saline irrigation suffices.
2. Adenoidal hypertrophy without inflammation — irrigation + topical steroid sprays are first-line.
3. Dry cough without bronchospasm (e.g., pharyngitis) — local lozenges, sprays, humidification more effective.
4. Prophylaxis in healthy children — “preventive” nebulization has no evidence-based benefit.
5. Acute purulent otitis media — systemic/local antibiotics indicated; nebulization not effective.

Contraindications

• Frequent epistaxis.
• Allergy or intolerance to nebulized drug components.
• Complete upper airway obstruction (requires emergency intervention).
• Ultrasonic nebulizers contraindicated for suspensions (e.g., budesonide).

Expert Note from KindCare Medical Center

Dr. Maryna Kryshtopava emphasizes that the nebulizer is not a universal remedy, but a targeted tool. It is indispensable for certain acute ENT conditions (croup, subglottic edema, severe rhinosinusitis), while in many other cases, traditional evidence-based methods (nasal irrigation, sprays, oral medications) remain more effective and safer.

From “Potatoes and Steam” to Modern Nebulizer Therapy

Inhalation is one of the oldest respiratory treatments. The evolution moved from folk methods—breathing steam over potatoes or herbal decoctions (with risks of burns and low efficacy)—to modern devices capable of delivering medications directly to the upper and lower airways as fine aerosol particles. Today’s nebulizers provide precise, safe, and efficient therapy by targeting the site of inflammation.

Mechanism of Action

Nebulizer therapy helps to:

• moisturize the mucosa and restore its protective function,
• reduce edema and inflammation,
• enhance mucociliary clearance,
• deliver drugs (antibiotics, corticosteroids, mucolytics, antiseptics) directly to the mucosal surface.

Indications

• Acute and chronic rhinitis.
• Sinusitis.
• Laryngitis, tracheitis, bronchitis.
• Allergic rhinitis.
• Postoperative ENT rehabilitation.

Modern Nebulizer Devices

1. Jet (compressor) nebulizers — universal, compatible with most solutions and some suspensions (e.g., budesonide), ideal for larger aerosol (MMAD 5–10 µm) deposition in upper airways.
2. Mesh (vibrating-membrane) nebulizers — quiet, portable, consistent aerosol; MMAD 3–5 µm (e.g., Omron MicroAir NE-U100). Useful with nasal adapters/masks for upper airways.
3. Specialized sinus devices — PARI SINUS2: pulsating aerosol enhances sinus penetration; indicated for rhinosinusitis, approved from age 6.
4. Adjustable-output devices — e.g., Omron A3, allow switching between particle sizes for upper vs. lower airway delivery.

Interfaces and Accessories

• Nasal cannulas/adapters → nose, nasopharynx, sinuses (with pulsation).
• Mask → nose + mouth, pharynx/larynx/trachea (preferred in children <5 years or debilitated patients).
• Mouthpiece → primarily larynx/trachea (inhalation through mouth, 1–2 s breath-hold).
• Target MMAD: 5–10 µm for nose/sinuses, 3–5 µm for larynx/trachea.

Solutions for Upper Airway Nebulization

• Isotonic 0.9% NaCl — baseline humidification, mucociliary support.
• Mild hypertonic 2–3% NaCl — osmotic decongestion (caution: burning/cough, avoid in infants without supervision).
• Mucolytics (ambroxol, acetylcysteine) — for thick mucus; assess risk of hyperreactivity.
• Inhaled corticosteroids (e.g., budesonide suspension) — strict indications (croup, post-op edema). Contraindicated with ultrasonic devices.
• Epinephrine/adrenaline — emergency use for croup or subglottic edema, only in clinical settings.

Not recommended: boiled water, mineral water, essential oils, herbal decoctions, antiseptic rinses (chlorhexidine, etc.), or non-sterile liquids (risk of bronchospasm, toxicity, device damage).

Algorithm for Choosing a Nebulizer (Upper Airways)

1. Target zone:
   • Nose/sinuses → PARI SINUS2 or jet/mesh with nasal adapter.
   • Nasopharynx/pharynx/larynx → mask or mouthpiece (slow inhalation, breath-hold).
2. Particle size:
   • Nose/sinuses: 5–10 µm;
   • Larynx/trachea: 3–5 µm.
3. Solution: saline baseline; hypertonic for edema; mucolytics/steroids by indication.
4. Patient compliance: noise/size intolerance → portable mesh device.
5. Hygiene & safety: meticulous cleaning/drying after each session.

Recommended Devices (Upper Airway Focus)

• PARI SINUS2 — pulsating aerosol for sinuses, ≥6 years.
• Omron MicroAir NE-U100 — portable mesh, silent, usable in any position.
• Omron A3 — adjustable output for upper/lower airway targeting.
• Philips InnoSpire Go — mesh technology, rapid therapy (mask/nasal breathing technique needed for upper airways).

Age Considerations

• <1 year — only under physician supervision.
• 1–6 years — short sessions (3–5 min).
• ≥6 years and adults — 7–10 min inhalations.

Rules of Nebulizer Use in ENT Disorders

• Patient seated upright, silent; nebulizer chamber strictly vertical.
• Check drug expiration date before use.
• Store opened vials in refrigerator, use within 2 weeks.
• Use sterile syringes/needles for filling; chamber volume ~4 mL.
• Breathing technique:
  • Pharynx/larynx/trachea → inhale orally, breath-hold 2 s, exhale nasally.
  • Nose/sinuses → breathe quietly through nose.
• Duration: 5–10 min per session.

After inhalation: rinse nebulizer with sterile water, dry thoroughly with lint-free wipes.

Patient Training at KindCare Medical Center

At KindCare Medical Center, Dr. Maryna Kryshtopava not only prescribes nebulizer therapy as part of treatment but also trains parents and adult patients in correct technique. During consultation, you will learn:

• how to safely perform inhalation for children and adults;
• which medications are appropriate for each clinical case;
• which devices are best suited;
• how to adapt therapy to age and health status.

Thus, patients receive not just treatment but practical skills that support airway health on a daily basis.